The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration

Journal of Biological Chemistry

Volumn 287, Issue 13, 2012, Pages 9792-9803

  Dong, Ying ^a   He, Yaowu ^b   De Boer, Leonore ^a   Stack, M Sharon ^c,e   Lumley, John W ^d   Clements, Judith A ^a   Hooper, John D ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c University of Missouri   (United States)

^d WESLEY HOSPITAL   (Australia)

^e UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-EGFR; CELL MIGRATION; CELL SURFACES; CELL-CELL JUNCTIONS; DOMAIN-CONTAINING PROTEINS; EGFR SIGNALING; EPIDERMAL GROWTH FACTORS; EPITHELIAL OVARIAN TUMORS; IMMUNOHISTOCHEMICAL ANALYSIS; KEY REGULATORS; OVARIAN CANCERS; PHARMACOLOGICAL AGENTS; UP-REGULATION;

CHEMICAL ACTIVATION; DISEASES; GLYCOPROTEINS; GROWTH KINETICS;

CELL MEMBRANES;

CELL SURFACE PROTEIN; CUB DOMAIN CONTAINING PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL JUNCTION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR JUNCTIONS; MAP KINASE SIGNALING SYSTEM; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PSEUDOPODIA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; UP-REGULATION;

EID: 84858986330     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.335448     Document Type: Article

References (61)

1. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., and Schlessinger, J. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425 (Pubitemid 14102443)
2. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P., Ward, C. W., and Burgess, A. W. (2003) Epidermal growth factor receptor. Mechanisms of activation and signalling. Exp. Cell Res. 284, 31-53 (Pubitemid 36331965)
3. Schneider, M. R., and Wolf, E. (2009) The epidermal growth factor receptor ligands at a glance. J. Cell. Physiol. 218, 460-466
4. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., and Salomon, D. S. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2-16 (Pubitemid 43199589)
5. Downward, J., Waterfield, M. D., and Parker, P. J. (1985) Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J. Biol. Chem. 260, 14538-14546 (Pubitemid 16210976)
6. Pierce, K. L., Tohgo, A., Ahn, S., Field, M. E., Luttrell, L. M., and Lefkowitz, R. J. (2001) Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors. A co-culture system for identifying intermediates upstream and downstream of heparin binding EGF shedding. J. Biol. Chem. 276, 23155-23160
7. Poon, S. L., Hammond, G. T., and Leung, P. C. (2009) Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion. Mol. Endocrinol. 23, 1646-1656
8. Mao, W., Irby, R., Coppola, D., Fu, L., Wloch, M., Turner, J., Yu, H., Garcia, R., Jove, R., and Yeatman, T. J. (1997) Activation of c-Src by receptor-tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15, 3083-3090 (Pubitemid 28043487)
9. Ricono, J. M., Huang, M., Barnes, L. A., Lau, S. K., Weis, S. M., Schlaepfer, D. D., Hanks, S. K., and Cheresh, D. A. (2009) Specific cross-talk between epidermal growth factor receptor and integrin αvβ5 promotes carcinoma cell invasion and metastasis. Cancer Res. 69, 1383-1391
10. Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signaling network. Nat. Rev. Mol. Cell Biol. 2, 127-137
11. Kim, L. C., Song, L., and Haura, E. B. (2009) Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 6, 587-595
12. Chung, B. M., Dimri, M., George, M., Reddi, A. L., Chen, G., Band, V., and Band, H. (2009) The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 28, 1821-1832
13. Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., and Parsons, S. J. (1995) Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src. Implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. U.S.A. 92, 6981-6985
14. Wells, A. (1999) EGF receptor. Int. J. Biochem. Cell Biol. 31, 637-643
15. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J., and Wagner, E. F. (2000) The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211-220
16. Shilo, B. Z. (2003) Signaling by the Drosophila epidermal growth factor receptor pathway during development. Exp. Cell Res. 284, 140-149
17. Ahmed, N., Thompson, E. W., and Quinn, M. A. (2007) Epithelial- mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas. An exception to the norm. J. Cell. Physiol. 213, 581-588 (Pubitemid 350058249)
18. Hudson, L. G., Zeineldin, R., and Stack, M. S. (2008) Phenotypic plasticity of neoplastic ovarian epithelium. Unique cadherin profiles in tumor progression. Clin. Exp. Metastasis 25, 643-655
19. Zeineldin, R., Muller, C. Y., Stack, M. S., and Hudson, L. G. (2010) Targeting the EGF receptor for ovarian cancer therapy. J. Oncol. 414676
20. Lu, Z., Ghosh, S., Wang, Z., and Hunter, T. (2003) Down-regulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 4, 499-515 (Pubitemid 38050046)
21. Lim, R., Ahmed, N., Borregaard, N., Riley, C., Wafai, R., Thompson, E. W., Quinn, M. A., and Rice, G. E. (2007) Neutrophil gelatinase-associated lipocalin (NGAL), an early-screening biomarker for ovarian cancer. NGALis associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int. J. Cancer 120, 2426-2434 (Pubitemid 46642130)
22. Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., and Ahmed, N. (2009) Cross-talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br. J. Cancer 100, 134-144
23. Lee, M. Y., Chou, C. Y., Tang, M. J., and Shen, M. R. (2008) Epithelial-mesenchymal transition in cervical cancer. Correlation with tumor progression, epidermal growth factor receptor overexpression, and snail upregulation. Clin. Cancer Res. 14, 4743-4750
24. Prenzel, N., Fischer, O. M., Streit, S., Hart, S., and Ullrich, A. (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Cancer 8, 11-31 (Pubitemid 32520251)
25. Wheeler, D. L., Dunn, E. F., and Harari, P. M. (2010) Understanding resistance to EGFR inhibitors. Impact on future treatment strategies. Nat. Rev. Clin. Oncol. 7, 493-507
26. Gotoh, N. (2011) Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors. Int. J. Clin. Exp. Pathol 4, 403-409
27. Scherl-Mostageer, M., Sommergruber, W., Abseher, R., Hauptmann, R., Ambros, P., and Schweifer, N. (2001) Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 20, 4402-4408 (Pubitemid 32726882)
28. Hooper, J. D., Zijlstra, A., Aimes, R. T., Liang, H., Claassen, G. F., Tarin, D., Testa, J. E., and Quigley, J. P. (2003) Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135- kDa cell surface phosphorylated glycoprotein antigen. Oncogene 22, 1783-1794 (Pubitemid 36513138)
29. Brown, T. A., Yang, T. M., Zaitsevskaia, T., Xia, Y., Dunn, C. A., Sigle, R. O., Knudsen, B., and Carter, W. G. (2004) Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/ CUB domain-containing protein 1 in epithelia. J. Biol. Chem. 279, 14772-14783 (Pubitemid 38618866)
30. Bhatt, A. S., Erdjument-Bromage, H., Tempst, P., Craik, C. S., and Moasser, M. M. (2005) Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24, 5333-5343 (Pubitemid 43080103)
31. Uekita, T., and Sakai, R. (2011) Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci. 102, 1943-1948
32. Wortmann, A., He, Y., Deryugina, E. I., Quigley, J. P., and Hooper, J. D. (2009) The cell surface glycoprotein CDCP1 in cancer. Insights, opportunities, and challenges. IUBMB Life 61, 723-730
33. Uekita, T., Tanaka, M., Takigahira, M., Miyazawa, Y., Nakanishi, Y., Kanai, Y., Yanagihara, K., and Sakai, R. (2008) CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am. J. Pathol. 172, 1729-1739 (Pubitemid 351793363)
34. Miyazawa, Y., Uekita, T., Hiraoka, N., Fujii, S., Kosuge, T., Kanai, Y., Nojima, Y., and Sakai, R. (2010) CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res. 70, 5136-5146
35. Siva, A. C., Wild, M. A., Kirkland, R. E., Nolan, M. J., Lin, B., Maruyama, T., Yantiri-Wernimont, F., Frederickson, S., Bowdish, K. S., and Xin, H. (2008) Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model. Cancer Res. 68, 3759-3766
36. Deryugina, E. I., Conn, E. M., Wortmann, A., Partridge, J. J., Kupriyanova, T. A., Ardi, V. C., Hooper, J. D., and Quigley, J. P. (2009) Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. Mol. Cancer Res. 7, 1197-1211
37. Casar, B., He, Y., Iconomou, M., Hooper, J. D., Quigley, J. P., and Deryugina, E. I. (2011) Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene, in press
38. Razorenova, O. V., Finger, E. C., Colavitti, R., Chernikova, S. B., Boiko, A. D., Chan, C. K., Krieg, A., Bedogni, B., LaGory, E., Weissman, I. L., Broome-Powell, M., and Giaccia, A. J. (2011) VHL loss in renal cell carcinoma leads to up-regulation ofCUBdomain-containing protein 1 to stimulate PKCδ-driven migration. Proc. Natl. Acad. Sci. U.S.A. 108, 1931-1936
39. Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., Stack, M. S., and Hudson, L. G. (2008) Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res. 68, 4606-4613
40. Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P. J., Nicklin, J., Samaratunga, H., and Clements, J. A. (2001) Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res. 7, 2363-2371 (Pubitemid 32751637)
41. Tsao, S. W., Mok, S. C., Fey, E. G., Fletcher, J. A., Wan, T. S., Chew, E. C., Muto, M. G., Knapp, R. C., and Berkowitz, R. S. (1995) Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp. Cell Res. 218, 499-507
42. Fischer, K., Lutz, V., Wilhelm, O., Schmitt, M., Graeff, H., Heiss, P., Nishiguchi, T., Harbeck, N., Kessler, H., Luther, T., Magdolen, V., and Reuning, U. (1998) Urokinase induces proliferation of human ovarian cancer cells. Characterization of structural elements required for growth factor function. FEBS Lett. 438, 101-105 (Pubitemid 28517843)
43. Dong, Y., Tan, O. L., Loessner, D., Stephens, C., Walpole, C., Boyle, G. M., Parsons, P. G., and Clements, J. A. (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the α5β1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res. 70, 2624-2633
44. He, Y., Wortmann, A., Burke, L. J., Reid, J. C., Adams, M. N., Abdul-Jabbar, I., Quigley, J. P., Leduc, R., Kirchhofer, D., and Hooper, J. D. (2010) Proteolysis- induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCδ. J. Biol. Chem. 285, 26162-26173
45. Wortmann, A., He, Y., Christensen, M. E., Linn, M., Lumley, J. W., Pollock, P. M., Waterhouse, N. J., and Hooper, J. D. (2011) Cellular settings mediating Src substrate switching between focal adhesion kinase tyrosine 861 and CUB domain-containing protein 1 (CDCP1) tyrosine 734. J. Biol. Chem. 286, 42303-42315
46. Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M., Takahashi, M., Takahashi, T., Hirai, H., Tushima, T., Akanuma, Y., Fujita, T., Komuro, I., Yazaki, Y., and Kadowaki, T. (1997) Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390, 91-96 (Pubitemid 27494763)
47. Levitzki, A., and Gazit, A. (1995) Tyrosine kinase inhibition. An approach to drug development. Science 267, 1782-1788
48. MacKeigan, J. P., Collins, T. S., and Ting, J. P. (2000) MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem. 275, 38953-38956 (Pubitemid 32058904)
49. Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., and Courtneidge, S. A. (2000) SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20, 9018-9027 (Pubitemid 32245931)
50. Ciardiello, F., and Tortora, G. (2008) EGFR antagonists in cancer treatment. N. Engl. J. Med. 358, 1160-1174
51. Uekita, T., Jia, L., Narisawa-Saito, M., Yokota, J., Kiyono, T., and Sakai, R. (2007) CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol. Cell. Biol. 27, 7649-7660 (Pubitemid 350033670)
52. Liu, H., Ong, S. E., Badu-Nkansah, K., Schindler, J., White, F. M., and Hynes, R. O. (2011) CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc. Natl. Acad. Sci. U.S.A. 108, 1379-1384
53. Benes, C. H., Poulogiannis, G., Cantley, L. C., and Soltoff, S. P. (2012) The SRC-associated protein CUB domain-containing Protein-1 regulates adhesion and motility. Oncogene 31, 653-663
54. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W., and Semenza, G. L. (2000) Modulation of hypoxiainducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells. Implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545 (Pubitemid 30183422)
55. Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., and Lee, S. (2005) Silencing of epidermal growth factor receptor suppresses hypoxia- inducible factor-2-driven VHL-/- renal cancer. Cancer Res. 65, 5221-5230 (Pubitemid 40827332)
56. Oda, K., Matsuoka, Y., Funahashi, A., and Kitano, H. (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol. 1, 0010
57. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumorprogression. Nat. Rev. Cancer 2, 442-454
58. Santin, A. D., Zhan, F., Bellone, S., Palmieri, M., Cane, S., Bignotti, E., Anfossi, S., Gokden, M., Dunn, D., Roman, J. J., O'Brien, T. J., Tian, E., Cannon, M. J., Shaughnessy, J., Jr., and Pecorelli, S. (2004) Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium. Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int. J. Cancer 112, 14-25 (Pubitemid 39249487)
59. Bendoraite, A., Knouf, E. C., Garg, K. S., Parkin, R. K., Kroh, E. M., O'Briant, K. C., Ventura, A. P., Godwin, A. K., Karlan, B. Y., Drescher, C. W., Urban, N., Knudsen, B. S., and Tewari, M. (2010) Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer. Evidence supporting a mesothelial-to-epithelial transition. Gynecol. Oncol. 116, 117-125
60. Strauss, R., Li, Z. Y., Liu, Y., Beyer, I., Persson, J., Sova, P., Möller, T., Pesonen, S., Hemminki, A., Hamerlik, P., Drescher, C., Urban, N., Bartek, J., and Lieber, A. (2011) Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 6, e16186
61. Ong, A., Maines-Bandiera, S. L., Roskelley, C. D., and Auersperg, N. (2000) An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int. J. Cancer 85, 430-437 (Pubitemid 30030419)